I also suspect there is some concern now about a placebo controlled high-risk group as the trial would take months (e.g., 2 months of safety data). Perhaps it needs to be non-inferiority, now. If it is inferior, it might not get an EUA, so a lot of risk is involved.
-
-
Ideas do not exist on their own. They have advocates.
- Show replies
New conversation -
-
In fact, the question you raise is pretty much all I think about: the new public sphere and how it operates.
-
Ok so my assumption is that advocating for a single shot will invite people to lower their confidence that a second shot is necessary. Can you explain why that assumption is wrong. I’ve picked it up from scientists who are talking another this.
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.